Syntactx: NAMSA Acquires Syntactx to Enhance End-to-End CRO Development Solutions, Expanding Medical Device Clinical Research Capabilities and Expertise
"Syntactx is very proud to join NAMSA, a long-recognized industry leader in CRO medical device development and clinical research services," stated Dr. Kenneth Ouriel, President and CEO of Syntactx.
Read full article »
Syntactx is a clinical research organization that offers clinical trials, medical device development, and regulatory consulting services.
Read more